This suggest that the detrimental effect of the aberrant activity of the TWEAK/Fn14 pathway in skeletal muscle of SOD1G93A ALS mice is driven by the receptor (Fn14) and not the ligand (TWEAK). This evidence concerns the gene TNFSF12 and amyotrophic lateral sclerosis.